Roche’s Evrysdi (risdiplam) is the market leader among the drugs for spinal muscular atrophy (SMA). Biogen’s Spinraza ...

As novel gene therapies emerge, there is a complex interplay among their potential benefits, the burdens they may impose and ...

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can ...